Sign in
4

Changes in Ownership

MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0001236927-25-000007

Director sold 129,172 shares at an average $370.24 ($47,825,149)

  • Director acquired 129,172 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
FRIEDMAN PAUL A Director 2025-08-13 Option exercise 10b5-1 +129,172 $9.45 $1,220,675 316,336 D: show line 1 in the form
FRIEDMAN PAUL A Director 2025-08-13 Sale 10b5-1 −1,600 $358.23 $573,171 314,736 D: show line 2 in the form
FRIEDMAN PAUL A Director 2025-08-13 Sale 10b5-1 −455 $359.31 $163,485 314,281 D: show line 3 in the form
FRIEDMAN PAUL A Director 2025-08-13 Sale 10b5-1 −3,153 $360.27 $1,135,938 311,128 D: show line 4 in the form
FRIEDMAN PAUL A Director 2025-08-13 Sale 10b5-1 −1,754 $361.13 $633,424 309,374 D: show line 5 in the form
FRIEDMAN PAUL A Director 2025-08-13 Sale 10b5-1 −1,439 $362.29 $521,332 307,935 D: show line 6 in the form
FRIEDMAN PAUL A Director 2025-08-13 Sale 10b5-1 −2,591 $363.08 $940,731 305,344 D: show line 7 in the form
FRIEDMAN PAUL A Director 2025-08-13 Sale 10b5-1 −3,529 $364.02 $1,284,639 301,815 D: show line 8 in the form
Open-market sales · 129,172 sh · avg $370.24 · $47,825,149

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
FRIEDMAN PAUL A Director 2025-08-13 Option exercise · Stock Option (Right to Buy) 10b5-1 −129,172 0 D: show line 19 in the form
Loading xslF345X05/wk-form4_1755123534.xml…